Obinutuzumab for the treatment of non-Hodgkin lymphomas

被引：0
|
作者：
Hernandez, Juana [1 ]
Nielsen, Tina [1 ]
Klein, Christian [1 ]
Wenger, Michael [1 ]
机构：
[1] F Hoffmann La Roche Ltd, Grenzacherstr 124, CH-4070 Basel, Switzerland
来源：
NATURE | 2018年 / 563卷 / 7731期
关键词：
FOLLICULAR LYMPHOMA; RITUXIMAB;
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Obinutuzumab for relapsed or refractory indolent non-Hodgkin's lymphomas
    Gabellier, Ludovic
    Cartron, Guillaume
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (02) : 85 - 93
  • [2] Treatment of indolent non-Hodgkin's Lymphomas
    Moreno Nogueira, J. A.
    Casas Fernandez de Tejerina, A.
    Moreno Rey, C.
    REVISTA CLINICA ESPANOLA, 2009, 209 (02): : 82 - 87
  • [3] Ofatumumab in the treatment of non-Hodgkin's lymphomas
    Karlin, Lionel
    Coiffier, Bertrand
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (07) : 1085 - 1091
  • [4] Treatment of aggressive non-Hodgkin's lymphomas
    Moreno Nogueira, J. A.
    Ruiz Borrego, M.
    Perez Valderrama, B.
    Valero Azbiru, M.
    REVISTA CLINICA ESPANOLA, 2009, 209 (02): : 88 - 92
  • [5] Radiotherapy for Non-Hodgkin Lymphomas
    Imber, Brandon S.
    Yahalom, Joachim
    CANCER JOURNAL, 2020, 26 (03) : 217 - 230
  • [6] Non-Hodgkin's Lymphomas
    Zelenetz, Andrew D.
    Abramson, Jeremy S.
    Advani, Ranjana H.
    Andreadis, C. Babis
    Byrd, John C.
    Czuczman, Myron S.
    Fayad, Luis
    Forero, Andres
    Glenn, Martha J.
    Gockerman, Jon P.
    Gordon, Leo I.
    Harris, Nancy Lee
    Hoppe, Richard T.
    Horwitz, Steven M.
    Kaminski, Mark S.
    Kim, Youn H.
    LaCasce, Ann S.
    Mughal, Tariq I.
    Nademanee, Auyporn
    Porcu, Pierluigi
    Press, Oliver
    Prosnitz, Leonard
    Reddy, Nashitha
    Smith, Mitchell R.
    Sokol, Lubomir
    Swinnen, Lode
    Vose, Julie M.
    Wierda, William G.
    Yahalom, Joachim
    Yunus, Furhan
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (03): : 288 - 334
  • [7] Recent Advances in the Treatment of Non-Hodgkin's Lymphomas
    Abramson, Jeremy S.
    Zelenetz, Andrew D.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (5.5): : 671 - 675
  • [8] Non-Hodgkin's Lymphomas
    Zelenetz, Andrew D.
    Abramson, Jeremy S.
    Advani, Ranjana H.
    Andreadis, C. Babis
    Bartlett, Nancy
    Bellam, Naresh
    Byrd, John C.
    Czuczman, Myron S.
    Fayad, Luis E.
    Glenn, Martha J.
    Gockerman, Jon P.
    Gordon, Leo I.
    Harris, Nancy Lee
    Hoppe, Richard T.
    Horwitz, Steven M.
    Kelsey, Christopher R.
    Kim, Youn H.
    LaCasce, Ann S.
    Nademanee, Auayporn
    Porcu, Pierluigi
    Press, Oliver
    Pro, Barbara
    Reddy, Nashitha
    Sokol, Lubomir
    Swinnen, Lode J.
    Tsien, Christina
    Vose, Julie M.
    Wierda, William G.
    Yahalom, Joachim
    Zafar, Nadeem
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (05): : 484 - 560
  • [9] Prognostic factors in Hodgkin and non-Hodgkin lymphomas
    Cuenca, X.
    Xhaard, A.
    Mounier, N.
    BULLETIN DU CANCER, 2009, 96 (04) : 461 - 473
  • [10] Treatment approaches of hard-to-treat non-Hodgkin lymphomas
    Nandagopal, Lakshminarayanan
    Mehta, Amitkumar
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (03) : 259 - 273
12345